Placental Mitochondrial Function in Gestational Diabetes
妊娠糖尿病中的胎盘线粒体功能
基本信息
- 批准号:10396015
- 负责人:
- 金额:$ 33.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-12 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse eventAffectAntioxidantsApoptosisBody mass indexCell CycleComplexCongenital AbnormalityDataDependenceDevelopmentDiabetes MellitusDichloroacetateDrug TargetingElderlyEnzymesEventFatty AcidsFeedbackFemaleFetal GrowthFetal Growth RetardationFetusFrequenciesFunctional disorderFutureGenerationsGestational AgeGestational DiabetesGlucoseGlutamineGlycolysisGoalsGrowth and Development functionHyperlipidemiaIn VitroInfantLipidsMaintenanceMelatoninMembrane PotentialsMetabolicMetabolismMitochondriaMothersNewborn InfantNon-Insulin-Dependent Diabetes MellitusObesityOxidative PhosphorylationOxidative StressPathway interactionsPharmaceutical PreparationsPharmacologyPlacentaPlasmaPre-EclampsiaPredispositionPregnancyPregnancy OutcomePregnancy in DiabeticsPrevalenceRespirationSignal TransductionSteroidsSubstrate SpecificitySuperoxidesTestingTherapeuticThinnessTissuesWomanWomen&aposs GroupWorkadverse outcomeantioxidant enzymecell growth regulationfatty acid oxidationfetalfetal programmingflexibilitygeneration differenceimprovedimproved outcomeinnovationlipidomelipidomicsmalematernal hyperglycemiamaternal obesitymetabolomemetabolomicsmitochondrial dysfunctionnovelobesity developmentoffspringoxidationprepregnancypreventprogramssexual dimorphismstillbirthtrophoblastuptake
项目摘要
Project Summary
Obesity (BMI>30) and gestational diabetes (GDM), which are both increasing in frequency, cause more
adverse events in pregnancy, including stillbirth, development of type 2 diabetes in later life and importantly
they also program the fetus for subsequent development of obesity and diabetes. Currently these adverse
outcomes can be reduced but not prevented by treating women with GDM. As the placenta regulates
maternal metabolism, fetal growth and development, alterations in its function affects both mother and fetus.
Energy to support placental function is generated via glycolysis, β-oxidation and oxidative phosphorylation
using glucose and fatty acids as substrates. Maternal hyperglycemia and hyperlipidemia seen with obesity and
GDM alter the type/amount of substrates available to the placenta and hence may alter placental metabolism
and energy generation. Recently we found that expression of fatty acid transporters and enzymes involved in
β-oxidation of fatty acids was altered in the placenta of pregnancies with obesity in a sexually dimorphic
manner. We also demonstrated that mitochondrial respiration, expression of mitochondrial complexes and
generation of ATP are reduced in trophoblast from women with pregnancies complicated by obesity and more
so in pregnancies complicated by type A2 GDM (requiring medication) compared to lean controls. This is
associated with increased oxidative stress, metabolic inflexibility (cannot use other substrates when glycolysis
is inhibited) in obesity, and increased glycolysis with GDM. We have exciting preliminary data that the
placenta can also use glutamine for energy generation and that placental fuel dependency between glucose,
fatty acids and glutamine is altered with obesity and GDM. Mitochondria which are involved in many placental
functions, generate superoxide anion. In many pathophysiologic states, including the placenta with obesity and
GDM there is excessive superoxide generation leading to oxidative stress, which can feedback and damage
mitochondria in a vicious cycle hence targeted pharmacologic approaches to improve mitochondrial
function are being widely promoted. Recently we demonstrated differences in oxidative stress and in
antioxidant enzymes in the placenta of obese women, again in a sexually dimorphic manner and have shown
that the antioxidant melatonin or the metabolic modulator dichloroacetate (DCA) will improve mitochondrial
respiration in trophoblast from obese women. Using maternal and fetal plasma and placental tissue from 8
groups of women (prepregnancy lean or obese, with or without GDM with either a male or a female fetus (n=8
each group) we will test the hypothesis that altered metabolomic and lipid profiles and oxidative stress seen in
the placenta with obesity GDM together with altered fatty acid uptake and oxidation leads to decreased
oxidative phosphorylation and altered fuel flexibility of mitochondria supporting placental function which can be
improved/normalized by novel specific mitochondrial targeting to reduce oxidative stress or to redirect cellular
metabolism. This translational work may form the basis for future therapeutic approaches in obesity or GDM.
项目摘要
肥胖(BMI>30)和妊娠期糖尿病(GDM)的发生频率都在增加,
妊娠期不良事件,包括死胎、晚年发生2型糖尿病,
它们还为胎儿随后的肥胖症和糖尿病的发展编程。目前,这些不良
结果可以减少,但不能通过治疗GDM妇女预防。随着胎盘调节
母体代谢、胎儿生长和发育,其功能的改变影响母体和胎儿。
支持胎盘功能的能量通过糖酵解、β-氧化和氧化磷酸化产生
使用葡萄糖和脂肪酸作为底物。母体高血糖和高脂血症伴肥胖,
GDM改变胎盘可用底物的类型/量,因此可能改变胎盘代谢
和能源生产。最近,我们发现脂肪酸转运蛋白和相关酶的表达与
肥胖孕妇胎盘中脂肪酸的β-氧化发生改变,
方式我们还证明了线粒体呼吸、线粒体复合物的表达和
妊娠合并肥胖的妇女滋养层中ATP的生成减少,
与瘦对照组相比,妊娠合并A2型GDM(需要药物治疗)也是如此。这是
与增加的氧化应激、代谢能力(糖酵解时不能使用其他底物)
在肥胖症中,糖酵解增加。我们有令人兴奋的初步数据,
胎盘也可以利用谷氨酰胺产生能量,
脂肪酸和谷氨酰胺随肥胖和GDM而改变。线粒体参与许多胎盘
功能,产生超氧阴离子。在许多病理生理状态下,包括胎盘肥胖和
GDM有过量的超氧化物生成导致氧化应激,从而产生反馈性损伤
因此,有针对性的药理学方法,以改善线粒体
功能得到广泛推广。最近,我们证明了氧化应激和
肥胖妇女胎盘中的抗氧化酶,再次以性别二型的方式,
抗氧化剂褪黑激素或代谢调节剂二氯乙酸(DCA)将改善线粒体
肥胖女性滋养层的呼吸。使用来自8名孕妇和胎儿的血浆和胎盘组织,
妇女组(孕前瘦或肥胖,有或无GDM,胎儿为男性或女性(n=8
每组),我们将检验以下假设:
胎盘肥胖GDM连同改变脂肪酸摄取和氧化导致减少
氧化磷酸化和改变的燃料灵活性的线粒体支持胎盘功能,可以
通过新的特异性线粒体靶向来改善/正常化,以减少氧化应激或重定向细胞
新陈代谢.这种转化工作可能成为肥胖或GDM未来治疗方法的基础。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Placental mitochondrial dysfunction with metabolic diseases: Therapeutic approaches.
- DOI:10.1016/j.bbadis.2020.165967
- 发表时间:2021-01-01
- 期刊:
- 影响因子:0
- 作者:Hebert JF;Myatt L
- 通讯作者:Myatt L
Metformin Impacts Human Syncytiotrophoblast Mitochondrial Function from Pregnancies Complicated by Obesity and Gestational Diabetes Mellitus in a Sexually Dimorphic Manner.
- DOI:10.3390/antiox12030719
- 发表时间:2023-03-14
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Differences in Glycolysis and Mitochondrial Respiration between Cytotrophoblast and Syncytiotrophoblast In-Vitro: Evidence for Sexual Dimorphism.
- DOI:10.3390/ijms221910875
- 发表时间:2021-10-08
- 期刊:
- 影响因子:5.6
- 作者:Bucher M;Kadam L;Ahuna K;Myatt L
- 通讯作者:Myatt L
Use of Glucose, Glutamine, and Fatty Acids for Trophoblast Respiration in Lean Women, Women With Obesity, and Women With Gestational Diabetes.
使用葡萄糖、谷氨酰胺和脂肪酸促进瘦女性、肥胖女性和妊娠期糖尿病女性的滋养层呼吸。
- DOI:10.1210/jc.2019-00166
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Wang,Yu;Bucher,Matthew;Myatt,Leslie
- 通讯作者:Myatt,Leslie
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLIE MYATT其他文献
LESLIE MYATT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESLIE MYATT', 18)}}的其他基金
Placental Mitochondrial Function in Gestational Diabetes
妊娠糖尿病中的胎盘线粒体功能
- 批准号:
9920017 - 财政年份:2018
- 资助金额:
$ 33.41万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
8707875 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
9353444 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
8741981 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
8650502 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Role of miR-210 in placental mitochondrial metabolism
miR-210在胎盘线粒体代谢中的作用
- 批准号:
8895208 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
9276325 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Effects of a Maternal Obesogenic Environment on DNA Methylation in the Placenta
母体肥胖环境对胎盘 DNA 甲基化的影响
- 批准号:
8491926 - 财政年份:2013
- 资助金额:
$ 33.41万 - 项目类别:
Molecular Mechanisms Linking Placental Nutrient Sensing and Fetal Programming
连接胎盘营养感应和胎儿编程的分子机制
- 批准号:
8432440 - 财政年份:2012
- 资助金额:
$ 33.41万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 33.41万 - 项目类别: